Showing 1 - 18 results of 18 for search 'Li Li, MD', query time: 0.06s
Refine Results
-
1
-
2
Challenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic by Chunhua Xu MD, Li Li MD, Wei Wang PhD
Published 2021-10-01
Article -
3
-
4
ALDH3B1 Is an Independent Prognostic Biomarker of Lung Adenocarcinoma by Hongmei Sun MD, Mingying Zhang MD, Li Li MD, Zongwen Huang MD
Published 2020-07-01
Article -
5
Carpenter's pigmentation mimicking ashy dermatosis associated with African padauk wood dust by Yiming Li, MD, PhD, Xiaoqin Xie, MD, Li Li, MD, PhD
Published 2018-05-01
Article -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Efficacy and Safety Assessment of Rivaroxaban for the Treatment of Cerebral Venous Sinus Thrombosis in a Chinese Population by Yi-ying Jiang MD, Li-jie Chen BD, Xiao-ju Wu BD, Guo-qiu Zhou BD, Dong-can Mo BD, Xiao-ling Li BD, Liu-yu Liu MD, Jian-li Li MD, Man Luo MD, PhD
Published 2022-12-01
Article -
15
A Phase-III Noninferiority, Randomized Controlled Trial of Letibotulinum Toxin A for the Improvement of Moderate-to-Severe Glabellar Wrinkles in China by Yun Xie, MD, Xiumin Yang, MD, PhD, Hong Liang, MD, PhD, Hongliang Bo, MD, PhD, Jianyun Lu, MD, PhD, Qing Guo, MD, Li Li, MD, PhD, Hyoung-jin Moon, MD, Qingfeng Li, MD, PhD
Published 2024-01-01
Article -
16
Experience on AMR Diagnosis and Treatment Following Liver Transplantation: Case Series by Yuanyi Mang, MD, Yang Gao, MD, Yan Yang, MD, Mei Dong, MD, Qian Yang, MD, Hong Li, MD, Jianghua Ran, MD, Li Li, MD, Jun Ma, MD, Guoyu Chen, MD, Bin Yang, MD, Ying Xie, MD, Yunsong Wu, MD, Yingpeng Zhao, MD, Shengning Zhang, MD
Published 2024-04-01
Article -
17
Insights From the Histopathologic Analysis of Acquired and Genetic Thoracic Aortic Aneurysms and Dissections by L. Maximilian Buja, MD, Bihong Zhao, MD, PhD, Humaira Sadaf, MD, Michelle McDonald, DO, Ana M. Segura, MD, Li Li, MD, PhD, Alana Cecchi, MS, Siddharth K. Prakash, MD, Rana O. Afifi, MD, Charles C. Miller, PhD, Anthony L. Estrera, MD, Dianna M. Milewicz, MD, PhD
Published 2024-02-01
Article -
18
Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer by Jiaqi Han MD, Desheng Xiao PhD, Chongqing Tan PhD, Xiaohui Zeng MD, Huabin Hu MD, Shan Zeng PhD, MD, Qin Jiang MD, Longjiang She MD, Linli Yao MD, Li Li MD, Lanhua Tang PhD, Jian Ma PhD, MD, Jin Huang PhD, MD, Liangfang Shen PhD, MD
Published 2020-02-01
Article